Plant-Derived Nanotherapeutics and Nanocarriers: Recent Progress and Future Directions
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Pharmaceutical Technology".
Deadline for manuscript submissions: 25 April 2025 | Viewed by 19846
Special Issue Editors
Interests: nanobiotechnology; drug delivery; green nanomaterials; polymeric nanoparticles; lipidic nanoparticles
Interests: nanobiotechnology; drug-delivery; green nanomaterials; natural molecules; nanoencapsulation
Special Issue Information
Dear Colleagues,
Plant-based nanocarriers play an important role in several biomedical applications, ranging from drug delivery to tissue engineering. Their unique properties, such as the ease of their surface functionalization, natural abundance, high stability and cost effectiveness, make them ideal candidates for health care applications. Plants are an invaluable source of different types of molecules, which are recognized to have several therapeutic properties, due to their chemical and structural diversity and the biodiversity of their components. Nowadays, it is unquestionable that nature-based products have been, and will be, key players for the development of advanced pharmaceutical formulations. Therefore, this Special Issue aims to publish original research and review articles focused on the development of plant-derived nanotherapeutics and nanocarriers for the development of better approaches to precision therapy.
Dr. Estefânia V.R. Campos
Dr. Jhones Luiz De Oliveira
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- plant-based nanomaterials
- green nanomaterials
- drug delivery
- natural nanotherapeutics
- pharmaceutical nanoformulations
- biogenic synthesis
- phytonanotechnology
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.